Hepatic Adenomata and Androgen Treatment

Publisher Website
Google Scholar
Abstract
To the editor: Androgenic-anabolic steroids have been implicated in the genesis of primary liver tumours. Benign hepatic adenomas are rare and, to our knowledge, no previous case associated with long-term treatment with a non-17-alpha alkylated derivative has been described. We report hepatic adenomata in a renal transplant patient who had previously received androgenic treatment for 12 years. Careful questioning showed that the patient had never received a 17-alpha alkylated compound. A 32-year-old man with Alport's syndrome, on chronic hemodialysis since March 1973, received a cadaveric renal allograft in June 1983. Treatment was started in February 1971, with intramuscular nandrolone phenpropionate,

This publication has 3 references indexed in Scilit: